Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.

Podobne zapisy

• Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
  od: Shiwen, X, i wsp.
  Wydane: (2006)
• Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
  od: S. Soldano, i wsp.
  Wydane: (2011-01-01)
• Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
  od: Alix Naert, i wsp.
  Wydane: (2013-01-01)
• CTGF overexpressing mice: a model for human scleroderma
  od: Sonnylal, S, i wsp.
  Wydane: (2006)
• Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
  od: Emma Di Poi, i wsp.
  Wydane: (2023-11-01)